In this study, KRGE attenuated neurological impairment, striatal neuronal death, microglial activation, several cytokines, iNOS, and activation of MAPKs and NF-κB pathways in a 3-NP-induced HD model. The gene discussed is NFKB1; the disease is Huntington disease.